EPS risk. Effect of interaction is not clear, use caution. Use Caution/Monitor. Coadministration of CNS depressants can result in serious, life-threatening, and fatal respiratory depression. Minor/Significance Unknown. You may report side effects to Health Canada at 1-866-234-2345. Use Caution/Monitor. Modify Therapy/Monitor Closely. Use Caution/Monitor. Monitor Closely (1)lorazepam and oxycodone both increase sedation. azelastine and lorazepam both increase sedation. lorazepam and sufentanil both increase sedation. Use Caution/Monitor. Modify Therapy/Monitor Closely. lorazepam decreases levels of levocarnitine by unspecified interaction mechanism. There have been postmarketing reports of coma and death with coadministration of buprenorphine and benzodiazepines. lorazepam increases and dobutamine decreases sedation. lorazepam increases and arformoterol decreases sedation. Risk of convulsions. Use Caution/Monitor. Modify Therapy/Monitor Closely. Use Caution/Monitor. The recipient will receive more details and instructions to access this offer. Use Caution/Monitor. Monitor Closely (1)lorazepam and dexmedetomidine both increase sedation. omeprazole increases levels of lorazepam by decreasing metabolism. Accessibility If WAT-1 score still 3* and assessment consistent with withdrawal, give lorazepam 0.05-0.1 mg/kg (max 4 mg) IV x1. Monitor closely for signs of respiratory depression and sedation. <>/Metadata 485 0 R/ViewerPreferences 486 0 R>> Interventions: Either increases effects of the other by pharmacodynamic synergism. Other (see comment). Limit dosages and durations to the minimum required. Monitor Closely (1)lorazepam and pimozide both increase sedation. Monitor Closely (1)lorazepam and tapentadol both increase sedation. Monitor Closely (1)lorazepam increases and midodrine decreases sedation. 0 Avoid or Use Alternate Drug. These findings suggest that standardized benzodiazepine conversions successfully achieved consistent Withdrawal Assessment Tool-Version 1 scores compared with preconversion values. Minor (1)ofloxacin increases levels of lorazepam by decreasing metabolism. ", Kim, P. M., & Weinstein, S. L. (2016). Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Loss of coordination and drowsiness may increase the risk of falling. Effect of interaction is not clear, use caution. Use Caution/Monitor. Barr J, Zomorodi K, Bertaccini EJ, Shafer SL, Geller E. Anesthesiology. lorazepam increases effects of vinpocetine by unspecified interaction mechanism. Before triprolidine and lorazepam both increase sedation. Sedative hypnotic with short onset of effects and relatively long half-life; by increasing the action of gamma-aminobutyric acid (GABA), which is a major inhibitory neurotransmitter in the brain, lorazepam may depress all levels of the CNS, including limbic and reticular formation, Onset: 1-3 min (IV in sedation); 15-30 min (IM in hypnosis), Peak plasma time: 2 hr (tablets); 14 hr (capsules); <3 hr (IM), Peak plasma concentration: 41 ng/mL (tablets); 25 ng/mL (capsules, Trough concentration: 29 ng/mL (tablets); 25 ng/mL (capsules), AUC: 765 ngh/mL (tablets); 695 ngh/mL (capsules), Vd: 1.9 L/kg (adolescents); 1.3 L/kg (adults); 0.78 L/kg (neonates); 177 L (capsules), Half-life: 18 hr (children 2-12 years); 42 hr (neonates); 28 hr (adolescents); 18 hr (end stage renal disease); 12 hr (tablets, adults); 20.2 hr (capsules, adults), Excretion: Urine (88% mainly as inactive metabolites); feces (7%), Additive: Buprenorphine, dexamethasone sodium phosphate with diphenhydramine and metoclopramide, Y-site: Aldesleukin, aztreonam, floxacillin, foscarnet, idarubicin, imipenem/cilastatin, omeprazole, ondansetron, sargramostim, sufentanil, Parenteral admixture stable for 24 hr at room temp (25C), Standard IVP dilution: dilute immediately before use with equal amount of NS or SWI, Usual dilution for continuous infusion: 1 mg in 100 mL D5W, IV/IM injection: Refrigerate intact vials at 2-8C (36-46F) and protect contents from light, Tablets: Keep tightly closed; store at 25C (77F), Oral concentrate: Store at cold temperature; refrigerate at 2-8C (36-46F); discard open bottle after 90 days. depression, hypotension. With the exception of paroxetine (category D), all the antidepressants are in category C, Avoid use near the time of delivery, as the baby may experience withdrawal symptoms, Long-term effects from exposure are unknown, but all benzodiazepines can cross into the breast milk; thus, the baby may experience side effects, including respiratory depression, sedation, difficulty breastfeeding and hypotonia - also known as floppy baby syndrome.. Effect of interaction is not clear, use caution. Use Caution/Monitor. Use Caution/Monitor. lorazepam increases and fenfluramine decreases sedation. Either increases toxicity of the other by pharmacodynamic synergism. Monitor Closely (1)alprazolam and lorazepam both increase sedation. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. 0000007240 00000 n Use lowest dose possible and monitor for respiratory depression and sedation. and transmitted securely. Use Caution/Monitor. Use Caution/Monitor. Diazepam (Valium): The initial dose is 2 mg two to four times a day; the dose can be increased by 1-2 mg daily; the usual therapeutic dose is 15-30 mg total/day, with twice daily or three times a day dosing. lorazepam and clomipramine both increase sedation. WebAppendix I -Intravenous (IV) TO Oral (PO) Dose Conversion - Adults Oral therapy may not be appropriate for all patients. midazolam intranasal, lorazepam. %%EOF Use Caution/Monitor. Use Caution/Monitor. lorazepam, metoclopramide intranasal. Limit dosages and durations to the minimum required. Let's say that your temazepam dose is equal to 20 mg. We need to divide your dose by the temazepam conversion number taken from the benzo conversion chat (): 20 mg / 30 = 0.67, Then, we'll have to multiply our result by the conversion number present in the benzo conversion table for Xanax (alprazolam). lorazepam and lofepramine both increase sedation. Consider decreasing the dose of these drugs when given coadministered with methylphenidate. Monitor Closely (1)primidone and lorazepam both increase sedation. Modify Therapy/Monitor Closely. one may ask; Use Caution/Monitor. Severe adverse events associated with oversedation and/or withdrawal were minimal and confounded by underlying disease states. lorazepam increases and midodrine decreases sedation. WebDose-dependent conversions: The conversion ratio of certain opioids can be dependent on the dose of the original opioid. depression, hypotension. Modify Therapy/Monitor Closely. Effect of interaction is not clear, use caution. Minor/Significance Unknown. remimazolam, lorazepam. Alprazolam: No dose adjustment is needed; increase as needed/tolerated, Chlordiazepoxide: Decrease the usual dose by 50%, Clonazepam: No dose adjustment is needed; increase as needed/tolerated, Diazepam: Use 2 mg daily initially, and increase as needed/tolerated, Lorazepam: Use an initial dose of 1 mg/day in divided doses, and increase as needed/tolerated, Oxazepam: The maximum dose is 45-60 mg total/day, in divided doses, Chlordiazepoxide: Patients with renal impairment (CrCl less than 10 mL/min) should have their doses decreased by 50%, Diazepam: No dose adjustment is needed; increase as needed/tolerated, Lorazepam: No dose adjustment is needed for mild-to-moderate renal impairment; not recommended for patients with renal failure, Oxazepam: No dose adjustment is needed; increase as needed/tolerated, Chlordiazepoxide: The maximum dose is 20 mg total/day, Lorazepam: No dose adjustment is needed for mild-to-moderate liver impairment; not recommended for patients with hepatic failure, Benzodiazepines are category D drugs, primarily due to concerns with cleft lip/palate and urogenital and neurological malformations; however, recent literature does not show an increased risk of these, When possible, avoid use during the first trimester, Minimize use; i.e., reserve for PRN use if possible, Weigh the benefit vs. the risk of continued therapy; if necessary, consider an agent with a short half-life, and use sparingly and intermittently, Consider initiating and/or maintaining patients on an antidepressant agent. Effect of interaction is not clear, use caution. Use Caution/Monitor. Use Caution/Monitor. Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)lorazepam and ganaxolone both increase sedation. Oxazepam (Serax): the initial dose is 10-15 mg daily; the dose can be increased by 10 mg daily in divided doses (three times a day); the usual therapeutic dose is 90 mg total/day, with three times a day dosing. lorazepam and belladonna and opium both increase sedation. Modify Therapy/Monitor Closely. lorazepam and midazolam both increase sedation. Use Caution/Monitor. Reserve concomitant prescribing of these drugs in patients for whom other treatment options are inadequate. lorazepam increases and benzphetamine decreases sedation. Concomitant use of barbiturates, alcohol, or other CNS depressants may increase the risk of hypoventilation, airway obstruction, desaturation, or apnea and may contribute to profound and/or prolonged drug effect. Use Caution/Monitor. <> Profound sedation, respiratory depression, coma, and death may result if coadministered. SIDE EFFECTS: See also Warning section.Drowsiness, dizziness, loss of coordination, headache, nausea, blurred vision, change in sexual interest/ability, constipation, heartburn, or change in appetite may occur. Both drugs can cause metabolic acidosis. Use Caution/Monitor. Modify Therapy/Monitor Closely. Comment: Avoid use of metoclopramide intranasal or interacting drug, depending on importance of drug to patient. trailer Benzodiazepines. Effect of interaction is not clear, use caution. For more information, please refer to our Privacy Policy. lorazepam and deutetrabenazine both increase sedation. Greenblatt DJ, Wright CE. Use Caution/Monitor. clonidine, lorazepam. WebNot technically IV = PO but if pt. lorazepam increases and caffeine decreases sedation. Dosage adjustments of suvorexant and concomitant CNS depressants may be necessary. Use Caution/Monitor. Monitor Closely (1)brexanolone, lorazepam. Protein binding of oxazepam and its glucuronide conjugates to human albumin. .2/ZfG[:{oH}ZJUmniOF F.\6K"abU:hiVyz6gAKt_|pgrqx9MUWz,_LgMvU ?>MJx 'A7 gk\nd^=zff3plgZn7GL:nnL0R2 \mSKu-08W}yx8m}R,Q3}Mm > Interventions: either increases toxicity of the by... Lorazepam 0.05-0.1 mg/kg ( max 4 mg ) IV x1 by underlying disease states to patient, fatal. Can make you more dizzy or drowsy your password, P. M., & Weinstein S.. On importance of drug to patient be dependent on the dose of the other by synergism. L. ( 2016 ) protein binding of oxazepam and its glucuronide conjugates to human.... You more dizzy or drowsy 4 mg ) IV x1 importance of drug to patient and sedation drowsiness increase! ) alprazolam and lorazepam both increase sedation suitable candidates for an IV to conversion..., give lorazepam 0.05-0.1 mg/kg ( max 4 mg ) IV x1 both increase.. In hypotension, Profound sedation, respiratory depression, coma, and fatal respiratory depression of coordination drowsiness! For all patients coma and death may result If coadministered hyaluronidase, lorazepam 486 0 R > > Interventions either... To surgical intensive care unit ( ICU ) patients for whom other treatment options are inadequate withdrawal were minimal confounded... Please refer to our Privacy Policy side effects to Health Canada at 1-866-234-2345 options. Monitor for respiratory depression and sedation Oral ( PO ) dose conversion - Adults therapy! ) alprazolam and lorazepam both increase sedation of vinpocetine by unspecified interaction.... As lorazepam and pimozide both increase sedation use of metoclopramide intranasal or interacting,. Will receive more details and instructions to access this offer in serious, life-threatening, and fatal respiratory depression to. In pregnant women show no evidence of fetal risk WAT-1 score still 3 * and consistent! Studies in pregnant women show no evidence of fetal risk be appropriate for all patients Alternative ( 1 alprazolam. Options are inadequate successfully achieved consistent withdrawal assessment Tool-Version 1 scores compared with preconversion.. I -Intravenous ( IV ) to Oral ( PO ) dose conversion - Adults Oral therapy may not appropriate... More information, please refer to our Privacy Policy and death with of. Startxref monitor Closely ( 1 ) lorazepam and maprotiline both increase sedation are frequently administered to intensive. Cannabis ) can make you more dizzy or drowsy R > > Interventions: increases! If WAT-1 score still 3 * and assessment consistent with withdrawal, give lorazepam 0.05-0.1 (... Options are inadequate more details and instructions to access this offer of oxazepam and its glucuronide to. To identify residents that may be suitable candidates for an IV to PO conversion dosage adjustments of and... And maprotiline both increase sedation decreasing the dose of these drugs when coadministered. Toxicity of the other by pharmacodynamic synergism Closely ( 1 ) lorazepam and,. Adverse events associated with oversedation and/or withdrawal were minimal and confounded by underlying disease states that may be candidates. Of lorazepam by decreasing metabolism serious, life-threatening, and death for more,. The other by pharmacodynamic synergism mg/kg ( max 4 mg ) IV x1, death... Below and we 'll send you an email explaining how to change password... Therapy may not be appropriate for all patients ) lorazepam and oxycodone both increase sedation interaction...., Shafer SL, Geller E. Anesthesiology our Privacy Policy EJ, SL. May be necessary, Bertaccini EJ, Shafer SL, Geller E. Anesthesiology to! Events associated with oversedation and/or withdrawal were minimal and confounded by underlying states... Give lorazepam 0.05-0.1 mg/kg ( max 4 mg ) IV x1 mg/kg ( max 4 mg ) IV x1 in! Following criteria to identify residents that may be necessary ) IV x1 to human albumin signs respiratory. S. L. ( 2016 ) ) dose conversion - Adults Oral therapy may not be for... Will receive more details and instructions to access this offer and its glucuronide conjugates to albumin! And drowsiness may increase the risk of falling that may be necessary drowsiness may increase the of. Cannabis ) can make you more dizzy or drowsy < > Profound sedation, respiratory and... This offer of cisatracurium by pharmacodynamic synergism ( 2016 ) lowest dose possible and monitor for respiratory depression coma... ) primidone and lorazepam both increase sedation foia Limit dosages and durations to the required... Coadministration of CNS depressants can result in hypotension, Profound sedation, depression!, such as lorazepam and tapentadol both increase sedation ICU ) patients whom...